ITGB1 and neoplasm: Our preclinical data on this function of ITGB1 are strengthened by clinical data from a collection of matched primary tumor and liver metastasis samples from patients with SCLC that indicate a clear/significant increase of ITGB1 in liver metastasis in comparison with the primary tumor.